# EDGAR Filing Document

**Accession Number:** 0001932393
**File Stem:** 0002131383-26-000004
**Filing Date:** 2026-5
**Character Count:** 11042
**Document Hash:** 07aeece14e57d431c0edf7a2fc4a3408
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002131383-26-000004.hdr.sgml**: 20260505

**ACCESSION NUMBER**: 0002131383-26-000004

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260429

**FILED AS OF DATE**: 20260505

**DATE AS OF CHANGE**: 20260505

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Estrampes Catherine
- **CENTRAL INDEX KEY:** 0002131383

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41528
- **FILM NUMBER:** 26940551

**MAIL ADDRESS:**
- **STREET 1:** 500 WEST MONROE STREET
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60661
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GE HealthCare Technologies Inc.
- **CENTRAL INDEX KEY:** 0001932393
- **STANDARD INDUSTRIAL CLASSIFICATION:** X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 882515116
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 500 WEST MONROE STREET
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60661
- **BUSINESS PHONE:** 833-735-1139

**MAIL ADDRESS:**
- **STREET 1:** 500 WEST MONROE STREET
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60661

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GE Healthcare Holding LLC
- **DATE OF NAME CHANGE:** 20220603

## Exhibit 24.1

**Exhibit 24.1**

**<u>Power of Attorney</u>**

KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints each of (i) Frank R. Jimenez and (ii) Jenny L. Lauth, signing SINGLY, the undersigned's true and lawful attorney-in-fact to:

(1) &nbsp;&nbsp;&nbsp;&nbsp;execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director or holder of ten percent (10%) or more of the registered class of securities of GE HealthCare Technologies Inc. (the "***Company***"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 (the "***Exchange Act***"), as amended, and the rules thereunder;

(2)&nbsp;&nbsp;&nbsp;&nbsp;If necessary, submit a Form ID to apply for and obtain EDGAR filing codes in order to file a Form 3 on behalf of the undersigned;

(3) &nbsp;&nbsp;&nbsp;&nbsp;do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment or amendments thereto and timely file such forms or amendments with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(4) &nbsp;&nbsp;&nbsp;&nbsp;take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

\* \* \* \* \*

------

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 16th day of April 2026.

By: <u>&nbsp;&nbsp;&nbsp;&nbsp;/s/ Catherine Estrampes&nbsp;&nbsp;&nbsp;&nbsp;_____</u><br>&nbsp;&nbsp;&nbsp;&nbsp;Name: Catherine Estrampes

*[Signature Page to Power of Attorney – Forms 3,4, & 5]*

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Estrampes Catherine<br><sub>(Last) (First) (Middle)</sub><br>500 W. MONROE STREET<br><sub>(Street)</sub><br>CHICAGO, IL 60661<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>GE HealthCare Technologies Inc. [ GEHC ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-04-29 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Commer. & Growth Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock, par value $0.01 per share | 24081<sup>(1)(2)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (right to buy) | <sup>(3)</sup> | 2026-09-30 | Common Stock, par value $0.01 per share | 3030 | $161.30 | D |  |
| Employee Stock Option (right to buy) | <sup>(3)</sup> | 2027-11-17 | Common Stock, par value $0.01 per share | 1606 | $99.21 | D |  |
| Employee Stock Option (right to buy) | <sup>(3)</sup> | 2028-03-19 | Common Stock, par value $0.01 per share | 4657 | $76.66 | D |  |
| Employee Stock Option (right to buy) | <sup>(3)</sup> | 2028-03-19 | Common Stock, par value $0.01 per share | 4592 | $76.66 | D |  |
| Employee Stock Option (right to buy) | <sup>(4)</sup> | 2033-02-01 | Common Stock, par value $0.01 per share | 14109 | $70.01 | D |  |
| Employee Stock Option (right to buy) | <sup>(5)</sup> | 2033-03-01 | Common Stock, par value $0.01 per share | 8336 | $75.30 | D |  |
| Employee Stock Option (right to buy) | <sup>(6)</sup> | 2034-03-01 | Common Stock, par value $0.01 per share | 8052 | $92.72 | D |  |
| Employee Stock Option (right to buy) | <sup>(7)</sup> | 2035-03-03 | Common Stock, par value $0.01 per share | 9923 | $86.45 | D |  |
| Employee Stock Option (right to buy) | <sup>(8)</sup> | 2036-03-02 | Common Stock, par value $0.01 per share | 16398 | $80.16 | D |  |

---

### Footnotes:

(1) Consists of (i) 14,374 shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock; (ii) 3,470 restricted stock units with respect to GE HealthCare common stock, granted on March 3, 2025, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028; and (iii) 6,237 restricted stock units with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

(2) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

(3) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the distribution of shares of GE HealthCare common stock by GE to holders of GE common stock on a pro rata basis, 100% of which is currently exercisable.

(4) Award of an employee stock option with respect to GE HealthCare common stock, granted on February 1, 2023, of which 100% is currently exercisable.

(5) Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2023, of which 100% is currently exercisable.

(6) Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2024, of which 100% is currently exercisable.

(7) Award of an employee stock option with respect to GE HealthCare common stock, granted on March 3, 2025, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028.

(8) Award of an employee stock option with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

**Remarks:**
Exhibit 24.1 - Power of Attorney

**Signature:** /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact  
**Date:** 2026-05-05

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**